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regimen in the management of MNGCTs (8). Williams 
et al. also recommended the superiority of therapy with 
cisplatin, etoposide and bleomycin compared to PVB regi- 
men in the treatment of advanced disseminated germ cell 
tumours (9). However, several investigators have recently 
reported that etoposide-containing chemotherapy increased 
risk of leukemia when used to treat germ cell tumours 
(10,ll). Therefore, we chose PVB regimen rather than 
CEBA regimen, although MNGCTs themselves may 
have a potential risk in development of haematological 
malignancies. 
We feel that a needle biopsy following a careful evalu- 
ation of CT findings and serological markers will be a 
rapid, safe, and unstressful procedure in differentiating 
MNGCTs from other mediastinal tumours in adult 
females, and that combination of cytoreductive surgery and 
intensive chemotherapy with cisplatin-based regimen is 
effective in cases of MNGCTs. 
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Introduction pneumonia, is a clinicopathological syndrome that has 
emerged in the past decade as an important cause of 
Idiopathic bronchiolitis obliterans with organizing 
pneumonia (BOOP), also known as cryptogenic organizing 
respiratory illness in adults (1,2). Clinically, patients with 
this syndrome have been reported to present with a short 
prodrome characterized by a viral-type illness, followed by 
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cough, dyspnea and constitutional symptoms. Organized 
inflammatory polipoid masses predominantly affecting 
distal bronchioles and alveolar ducts are the major patho- 
logical findings. The course of this entity has usually been 
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FIG. 1. Radiograph of the chest obtained on admission to 
hospital showing bilateral patchy opacification of both 
lung fields. 
described as subacute and in most of the early reports 
BOOP is characterized by a good prognosis and excellent 
response to steroids. However, an acute and fulminating 
form of BOOP has been recently described (335). We 
present a case of adult respiratory distress syndrome 
(ARDS) due to idiopathic BOOP. Early recognition of 
the entity and prompt initiation of immunosuppressive 
therapy was instrumental in leading to a favourable out- 
come. Azathioprine administration allowed a tapering of 
the corticosteroid dose without worsening the patient’s 
condition. 
Case Report 
A 66-year-old woman was admitted to our hospital because 
of a 2-week history of fever, progressive dyspnea and a 
non-productive cough unresponsive to erythromycin. These 
symptoms appeared following an influenza-like illness 
1 month earlier. There was no history of connective-tissue 
disease and the patient denied toxic gas inhalations or drug 
ingestion. 
On admission her body temperature was 38°C; respira- 
tory rate 36 min- r; blood pressure 120/60 mmHg and 
heart rate 120 beats min - ‘. On examination she was thin 
and cyanosed, no lymphadenopathy was found and dry 
crackles were audible over both lung fields. The haema- 
tocrit was 43% and the white cell count 21 400 
cells mm - 3 with 78% neutrophils, 11% lymphocytes and 
1% eosinophils. The erythrocyte sedimentation rate was 
96 mm hour - ‘. Antinuclear antibodies and rheumatoid 
factor were negative. Complement levels were normal. A 
mild increase in total level of immunoglobulin G was 
observed. Breathing room air, arterial blood gas values 
were PaO, 5.2 KPa; PaCO, 4.5 KPa and pH 7.47. Despite 
a RIO, of 40%, severe hypoxemia (PaO, 6.2 KPa) per- 
sisted. A chest radiograph showed diffuse patchy opacities 
involving both lung fields. No evidence of pleural disease 
was observed (Fig. 1). 
FIG. 2. Photomicrograph showing buds of granulation 
tissue occupying most of the alveoli and a mild chronic 
inflammatory infiltrate involving adjacent alveolar walls. 
Stain: haematoxylin and eosin; original magnification 
x 60. 
Although an infectious aetiology could not be proven, 
the patient was initially treated with erythromycin 
and cefotaxime intravenously. On the second day after 
admission, her oxygen supplementation requirements were 
increased and methylprednisolone (40 mg i.v. daily) was 
started as we suspected an inflammatory disease. Micro- 
biological examination of sputum and blood were nega- 
tive. The patient’s condition did not improve. For this 
reason an open-lung biopsy was performed 48 h later. The 
biopsy was diagnostic of BOOP (Fig. 2). The lung tissue 
obtained was submitted for cultures and a detailed sero- 
logical evaluation was conducted including measurement 
of titres for viruses, mycoplasma, legionella, chlamydia 
and coxiella. None of these serological titres or the tissue 
cultures were positive. The patient required mechanical 
ventilation postoperatively for a total of 18 days. On day 
7 after admission, once the biopsy results had been 
obtained, antibiotic therapy was stopped and high-dose 
steroids were started: an initial bolus of methylpred- 
nisolone (1 g) followed by 40 mg every 6 h intravenously. 
Further hospital course was complicated by Acinetobacter 
calcoaceticus pneumonia which responded to antibiotic 
therapy. The patient’s respiratory status improved gradu- 
ally and she was weaned off mechanical ventilation on the 
22nd hospital day. Then, diffuse limb weakness against 
resistance was noted. She could not stand or use eating 
utensils. Acute steroid myopathy was suspected. Azathio- 
prine (150 mg daily) was added on the 32nd hospital day 
and the methylprednisolone dose was rapidly tapered. 
Two months later, steroid therapy was discontinued and 
the patient was discharged with her PaO, above 9.5 KPa. 
By that time, she was able to walk short distances on 
parallel bars. The patient was followed-up regularly for 
the next 8 months. She was treated with azathioprine 
(150 mg daily) without relapse, although effort dyspnea, 
bilateral interstitial infiltrates and mild hypoxemia still 
persisted. 
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Discussion 
Idiopathic BOOP is a distinct clinical and pathological 
syndrome of unknown aetiology. Although it usually has 
an indolent course and good prognosis, some recently 
reported cases represent an acute and life-threatening vari- 
ant of the syndrome (3-S). In this report we describe a 
patient who developed an ARDS due to idopathic BOOP. 
The diagnosis of BOOP was made according to the histo- 
logical features found in the lung tissue. The ARDS was 
diagnosed according to criteria based on clinical obser- 
vation and physiological measurement (6). On admission, 
the patient met these criteria: an arterial oxygen tension 
(mmHg) to inspired oxygen tension ratio of less than 200 
and bilateral multilobe infiltrates on chest X-rays without 
clinical evidence of left ventricular failure, intravenous fluid 
overload or prior parenchymal disease. 
ARDS may occur in response to various direct or indirect 
insults to the lung. The pathological features of the lung in 
ARDS have been labelled diffuse alveolar damage (DAD) 
and show a relatively broad spectrum. In the organizing 
stage, DAD may show granulation tissue polyps in bron- 
chioles and alveolar ducts. In contrast to BOOP, DAD 
usually shows hyaline membranes and prominent hyalinous 
exudates with or without organization, but when these 
features are dissipating, in the phase of DAD, differential 
diagnosis on histological features alone may be difficult. 
Patients who survive an episode of ARDS may be asymp- 
tomatic and have normal pulmonary function, or they may 
have marked dyspnea and severe physiological abnor- 
malities. On the other hand, the histological picture of 
BOOP may be a manifestation of early lung injury that can 
resolve or progress rapidly to alveolar septal inflammation, 
end-stage fibrosis and honeycombing. 
The histological pattern found in the lungs of patients 
with BOOP also occurs in cases of connective-tissue disease, 
eosinophilic pneumonia, some drug-induced pneumonias, 
radiation pneumonitis and some infections. Our patient 
denied toxic gas inhalation or drug ingestion. A detailed 
serological evaluation was conducted to rule out infections. 
The patient’s medical history was unremarkable prior to 
admission. She has been followed up for 8 months post- 
discharge and she did not show clinical or biochemical signs 
of an immunological disorder such as an autoimmune or 
connective-tissue disease. Therefore, we were unable to find 
a specific cause in the development of BOOP. 
Although we are aware of the rarity of this presentation, 
we believe that BOOP should be added to the list of 
numerous causes of ARDS. Nizami et al. (4) reported five 
patients with a fulminating variant of idiopathic BOOP. 
The two patients who died were those in whom cortico- 
steroid therapy was not initiated early on during the course 
of the illness. Cohen et al. (3) described 10 patients with 
rapidly progressive BOOP, seven of whom died despite 
aggressive therapy. Careful analysis of these patients reveals 
that two may have suffered from idiopathic BOOP. They 
have suggested that cases with a poor prognosis are those in 
which BOOP is associated with another chronic disease 
process, specially connective-tissue disease, autoimmune 
disease, exposure to drugs or environmental agents. We 
describe a case of idiopathic BOOP preventing with ARDS. 
Prompt initiation of immunosuppressive therapy led to a 
satisfactory outcome, but it did not prevent the develop- 
ment of chronic fibrosis. This complication was also 
reported by others (3,4). Hence, it is possible that the 
likelihood of response to treatment correlates not only with 
early initiation of immunosuppressive therapy but also with 
the extent of active alveolitis and fibrosis. 
Our patient developed acute quadriparesis that was 
attributed to high-dose steroid therapy. Since the original 
description (7), many patients have been reported to 
develop acute myopathy following high-dose steroid 
therapy. The condition usually improves over several 
months but it makes steroid suppression imperative. 
Azathioprine has been successfully employed in the treat- 
ment of idiopathic pulmonary fibrosis and obliterative 
bronchiolitis, both of which possess inflammatory and 
immune components of their pathogenesis. This drug is 
generally well tolerated although adverse effects can 
include bone marrow suppression, gastrointestinal dis- 
tress, pancreatitis, hepatitis, alopecia, dermatitis and retin- 
opathy. The good outcome for our patient suggests that 
azathioprine can be used as a corticosteroid-sparing agent 
in patients with BOOP. In this sense, considering that 
long-term treatment with corticosteroids often increases 
the risk of several undesirable effects and because relapse 
tends to occur after treatment is stopped, azathioprine 
could be a reasonable therapeutic choice to prevent 
recurrence and avoid further interstitial pneumonitis 
progression. 
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